AI assistant
Sending…
Altimmune, Inc. — Director's Dealing 2019
Sep 11, 2019
33207_dirs_2019-09-11_6121963d-a0a0-4ad2-b5b3-8a6fb0739ede.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2019-09-09
Reporting Person: Harris Matthew Scott (Chief Medical Officer)
More from Altimmune, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 17
Proxy Solicitation & Information Statement
2026
Mar 17
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 6